Perfusion System Market Key Players are Repligen Corporation and Spectrum Laboratories, Inc.

San Francisco, Calif., USA, Mar 23, 2023 — /EPR Network/ —

Perfusion System Industry Overview

The global perfusion system market size was valued at USD 1.02 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. Factors such as an increase in the prevalence of cardiovascular and respiratory diseases, a rise in the number of organ transplants, growth in the geriatric population, and increasing cases of organ failures are expected to drive the growth of the market. Factors such as growing investment in cell-based research, government & NGO initiatives to encourage organ donations, and a rise in biologics manufacturing are also expected to boost the market growth in the coming years. The COVID-19 pandemic had a slightly negative impact on the market. While cardiac surgeries were still carried out due to their chronic and life-threatening nature, there was a significant drop in the number of organ donations and transplants due to government-imposed lockdowns and restrictions. Thus, the market experienced a significant fall in perfusion system sales during the pandemic.

U.S. perfusion system market size, by application, 2020 - 2030 (USD Million)

Moreover, these lockdowns and restrictions disrupted the manufacturing processes as well as the overall supply chain across industries. They also resulted in disruption of research and development activities, which potentially led to the postponement of the launch of new products in the market. In addition, reduced patient visits to hospitals as a precautionary measure to avoid contracting the virus also had a significant negative impact on the industry.

Gather more insights about the market drivers, restraints, and growth of the Global Perfusion System market

However, with the world now returning to normalcy and countries majorly focusing on strengthening their healthcare setup, the market for perfusion systems is expected to continue generating a significant amount of revenue during the forecast period. With the imminent launch of new products, the market is expected to experience a pre-COVID growth rate during the forecast period.

A rise in the prevalence of cardiac and respiratory diseases is majorly contributing to the growth of the perfusion system market. Factors such as increasing consumption of processed food, a reduction in physical activity, and an increase in the overall lifespan of individuals, resulting in an increase in the geriatric population, are responsible for a rise in the prevalence of these disorders. According to the CDC’s 2022 data, in the U.S., every year about 805,000 people have a heart attack, and out of this, 605,000 people experience it for the first time.

A rise in the number of organ transplants is another factor that is expected to boost the market growth to a great extent during the forecast period. According to the preliminary data from the United Network of Organ Sharing, in 2021, the U.S. observed a 5.9% rise in organ transplants from 2020. The data also stated that, in 2021, around 13,861 Americans became deceased organ donors.  

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Arterial Cannula Market – The global arterial cannula market size was valued at USD 19.2 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Cerebral Oximetry Monitoring Market – The global cerebral oximetry monitoring market size was valued at USD 202.65 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Perfusion System Market Segmentation

Grand View Research has segmented the global perfusion system market based on application and region:

Perfusion System Application Outlook (Revenue, USD Million, 2017 – 2030)

  • Cardiopulmonary Perfusion System
  • Cell Perfusion System
  • Ex-vivo Organ Perfusion System

Perfusion System Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Market Share Insights

April 2022: LivaNova announced the commercial launch of the Essenz patient monitor. The monitor uses a patient-tailored approach to improve the efficiency and quality of care during cardiopulmonary bypass (CPB) procedures.

Key Companies profiled:

The following are some of the major players operating in the global perfusion system market:

  • Getinge AB
  • Medtronic, plc
  • LivaNova
  • Terumo Corporation
  • Nipro Corporation
  • XENIOS AG
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Merck KGaA
  • Harvard Bioscience, Inc.
  • ALA Scientific Instruments, Inc.
  • Lifeline Scientific, Inc.
  • XVIVO Perfusion AB

Order a free sample PDF of the Perfusion System Market Intelligence Study, published by Grand View Research.

Matched content

Editor’s pick

Express Press Release Distribution